Search - tctmd.com

November 22, 2017

News Opinion Off Script TCT 2017

Off Script: Connecting and Collaborating in the Global Village of Interventional Cardiology

Kwan S. Lee

November 01, 2017

Presentation TCT 2017

Twitter, Facebook, and Instagram 101: The Basics

Presenter: C. Michael Gibson, Shelley Wood, Sheila Sahni

November 01, 2017

News Opinion Fellow Talk

My Picks for Fellows Attending TCT 2017

Amit K. Gupta, MBBS, MD

October 26, 2017

News Opinion Fellow Talk

Why All Interventionalists Should Be on Twitter

Amit K. Gupta, MBBS, MD

October 18, 2017

News Featured Fellow

Nirmanmoh Bhatia, MD

July 11, 2017

News Daily News

Medical Journal Editors Back Off Ambitious Data-Sharing Mandate for Publication

June 07, 2017

News Conference News SCAI 2017

#SoMe for #SciComm? Cardiologists See Value in Social Media, With Some Caveats

L.A. McKeown

May 10, 2017

News Conference News ACC 2017

My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time

March 23, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

March 10, 2017

News Opinion Fellow Talk

美国总统选举是场闹剧：这不是我认识的美国

December 02, 2016

News Opinion Fellow Talk

The US Presidential Election Rhetoric: Not the America I Know

December 02, 2016

News Opinion Fellow Talk

La Retórica de las Elecciones Presidenciales Norteamericanas: No es la América que Conozco

December 02, 2016

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

November 09, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2016

Caitlin E. Cox

October 29, 2016

News Opinion Fellow Talk

My Picks for Fellows Attending TCT 2016

October 27, 2016

News Features

We Asked, You Answered: Exercise by the Numbers

October 26, 2016

News Daily News

Twitter Review Reveals Clues as to Who, When, and What Users Are Tweeting About Cardiovascular Disease Online

September 28, 2016

News Daily News

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond